Oof Sarepta...

Gene therapy company falls 45% in premarket trading after latest drug shows mixed results. [Trade of the Day Wake-Up Watchlist] Attention Readers: Our Head Trading Tactician Bryan Bottarelli has a bonus video for you today. Here you'll learn the absolute BEST times to start trading. Click the image below to see when Bryan prefers to trade. If you want to make live trades with Bryan in real time, we recommend checking out [The War Room](. Last week Bryan closed 5-of-7 winning trades for a 71% win rate, including a 23% win on RTX in 1 trading day. [Isn’t it time you got in on the action? Click here to unlock The War Room.]( Good morning Wake-up Watchlisters! While you’re sipping coffee you’ll see stock futures were up on Tuesday. Wall Street’s main indexes are in the midst of a rebound after the recent selloff, which was ignited by higher Treasury yields and the Middle East conflict. But overall, U.S. equities are tracking their third straight month in the red, with the S&P 500 and the Nasdaq on course for their worst October since 2018. While the markets have been volatile, we’ve been keeping our winning trading consistent. Last week our Lead Technical Tactician Nate Bear posted a 100% win rate in his latest service, [Profit Surge Trader](. He even closed a trade on GOOGL for a 100% gain in 8 trading days. [Click here to start trading alongside Nate as he trades ONE TICKER over and over again for maximum potential gains.]( Here’s a look at the top-moving stocks this morning. Pinterest (NYSE: PINS) Pinterest is up 16.73% premarket. The social media company posted strong third-quarter numbers. Adjusted earnings of $0.28 per share topped estimates of $0.20. Revenue was $763.2 million versus an expectation of $744.1 million. It also outperformed active user expectations, recording 482 million compared to an estimate of 473.46 million. [Alex Green's #1 Investment]( [Alex on set]( He believes in it so much that he's putting in over $100,000 of his own money... But YOU can get in for as little as $3. [Click Here to Get All the Details]( Sarepta Therapeutics (Nasdaq: SRPT) Sarepta Therapeutics is down 45.07% premarket after the gene therapy company unveiled mixed results for a drug that targets a muscle-wasting disease in boys. The drug is called Elevudiys, and patients who received a one-time dose noted a 2.6-point improvement on a 34-point scale measuring movement vs. a 1.9 improvement from placebo recipients. The results weren’t statistically significant. Cameco Corporation (NYSE: CCJ) Cameco Corporation is up 4.31% premarket. The nuclear energy company reported net earnings of $148 million and adjusted net earnings of $137 million. Its gross profit improved due to lower unit costs the uranium segment. Its market-related contracts also benefitted from increases in the uranium spot price relative to a year ago. Those are the biggest stock movers for today. Happy trading! The Wake-Up Watchlist Research Team [See What One Ticker... One Trade... EVERY WEEK... Can Do for YOU]( [Calendar; January - June]( New research proves that trading one ticker every week has had the ability to produce extraordinary gains... Including a rare 2,614% in under 11 days. See this groundbreaking new discovery for yourself. [SHOW ME ONE TICKER PAYOUTS]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2023 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.